Grenzen und Möglichkeiten der Therapie von Rhythmusstörungen im Hinblick auf den plötzlichen Herztod

H. Mösslacher

doi:10.1055/s-0038-1656389

Hämostaseologie, Inhaltsverzeichnis

Hamostaseologie 1982; 02(01): 8-17
DOI: 10.1055/s-0038-1656389

Originalarbeiten

Schattauer GmbH

Grenzen und Möglichkeiten der Therapie von Rhythmusstörungen im Hinblick auf den plötzlichen Herztod

H. Mösslacher

¹I. Medizinischen Univ.-Klinik Wien (Vorstand: Prof. Dr. Dr. h. c. E. Deutsch)

LITERATUR
1 Kuller L., Lilienfeld A., Fisher R.. Epidemiological study of sudden and unexpected deaths due to arteriosclerotic heart disease. Circulation 1966; 34: 1056-1068
2 Lown B.. Sudden cardiac death: The major challenge confronting contemporary cardiology. Am. J. Cardiol. 1979; 43: 313-328
3 Pantridge J., Geddes S.. A mobile intensive care unit in the management of myocardial infarction. Lancet 1967; 2: 271
4 Pantridge J. F.. Prehospital coronary care. Brit. Heart J. 1974; 26: 233-237
5 Iseri L., Humphrey S.. Prehospital brady-asysto-lic cardiac arrest. Ann. Intern. Med. 1978; 88: 741
6 Adgey A. A. J., Geddes J. S., Mülholland H. C., Keegan D. A. J., Pantridge J. F.. Incidence. significance and management of early brady-arrhythmias complicating acute myocardial infarction. Lancet 1968; 2: 1097
7 Bashe W. J., Baba N.. et al. Pathology of atherosclerotic heart disease in sudden death. II: The significance of myocardial infarction. Circulation 1975; 51/52 (Suppl. III) 63
8 Baroldi G., Falzi G., Mariani F.. Sudden coronary death. A postmortem study in 208 selected cases compared to 97 »control« subjects. Am. Heart J. 1979; 98: 20-31
9 Grace W. J.. Sudden death and acute myocardial infarction - what are we talking about (editorial). Am. Heart J. 1976; 91: 1-2
10 Lown B.. New concepts and approaches to sudden death. Schweiz med. Wschr. 1976; 106: 1522-1531
11 Reichenbach D. D., Moss N. S., Meyer E.. Pathology of the heart in sudden death. Am. J. Cardiol. 1977; 39: 865-872
12 Roberts W. L., Buja L. W.. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am. J. Med. 1972; 52: 425
13 Spain D. M., Brades V. A.. Frequency of coronary thrombi as related to duration of survival from onset of acute fatal episodes of myocardial isch-aemia. Circulation 1960; 22: 816
14 Lovegrove T., Thompson P.. The role of acute myocardial infarction in sudden cardiac death - a statistician nightmare. Am. Heart J. 96: 711 1978;
15 Weaver W. D.. et al Angiographic findings and prognostic indicators in patients resuscitated from sudden death. Circulation 1976; 54: 895
16 Cobb L. A., Hallstrom A. P.. et al: Prognostic factors in patients resuscitated from sudden cardiac death. In Hjalmarson A. L., Wilhelmsen L.. (eds) Acute and longterm medical treatment of myocardial ischaemia. Hässl, Mölntal 1978
17 Schaffer W. A., Cobb L. A.. Recurrent ventricular fibrillation and modes of death in survivors of out of hospital ventricular fibrillation. New Engl. J. Med. 1975; 293: 259-262
18 Wellens H. J. J., Düren D. R., Lie K. J.. Observations on mechanism of ventricular tachycardia in man. Circulation 1976; 54: 237
19 Myberg R. J., Steward J. W., Hoffman B. I.. Electrophysical properties of the canine peripheral av - conducting system. Circulation Res. 1970; 26: 361
20 Lown B., Wolf M.. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130
21 van Durme J. P., Pannier R.. Prevalence and prognostic significance of ventricular dysrhythmias during the first year after myocardial infarction. In Mäurer W. A., Schöming R., Dietz P., Lichtlen R.. (eds.) Betablockade 1977. Thieme; Stuttgart: 1978: 286
22 Ruberman W., Weinblatt E.. et al. Prognostic value of one hour of EKG-monitoring of man with coronary heart disease. J. chron. Dis. 1976; 29: 497-512
23 Schulze R. A., Strauss H. W., Pitt B.. Sudden death in the year following myocardial infarction. Am. J. Med. 1977; 62: 192
24 Vismara L. A., Amsterdam E. A., Mason D. T.. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death of hospital discharge. Am. J. Med. 1975; 59: 6
25 The Coronary Drug Project Research Group Prognostic importance of premature beats following myocardial infarction. Experience in the coronary drug project. JAMA 1973; 223: 1116
26 Ruberman W. E., Weinblatt E., Goldberg J. D.. et al. Ventricular premature beats and mortality after myocardial infarction. New Engl. J. Med. 1977; 297: 750
27 El Sherif N., Myerburg R. J., Scherlag J., Befeler B., Aranda J. M., Castellanos A., Lazzara R.. Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R on T-phenomenon in myocardial infarction. Brit. Heart J. 1976; 38: 415
28 Bennet M. A., Pentecost B. L.. Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet 1972; 1: 1351
29 Lie K. J., Wellens H. J. J., Durrer D.. Characteristics and predictability of primary ventricular fibrillation. Europ. J. Cardiol. 1974; 1: 379
30 Lie K. J., Wellens H. J. J., Dorner E., Durrer D.. Observations in patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 1975; 52: 755
31 Seipel L.. Warnarrhythmien und Lidocainpro-phylaxe beim Herzinfarkt. Dtsch. med. Wschr. 1977; 102: 1041-1042
32 Califf R. M., Burks J. M.. et al. Relationship among ventricular arrhythmias. Coronary artery disease and angiographic and electrocardiographic indicators of myocardial fibrosis. Circulation 1978; 57: 725
33 Calvert A., Lown B., Gorlin R.. Ventricular premature beats and anatomically defined coronary heart disease. Am. J. Cardiol. 1977; 39: 627-634
34 Lichtlen P. R., Bethge K. P., Platiel H.. Inzidenz des plötzlichen Herztodes bei Koronarpatienten in Abhängigkeit von Anatomie und Rhythmus-profil. Z. Kardiol. 1980; 69: 639-648
35 Sharma S. D., Ballantyne F., Goldstein S.. The relationship of ventricular asynergy in coronary artery disease to ventricular premature beats. Chest 1974; 66: 358-362
36 Schulze R. A., Humphries J., O'Neal J.. Left ventricular and coronary angiographic anatomy -relationship to ventricular irritability in the late hospital phase of acute myocardial infarction. Circulation 1977; 55: 839
37 Matta R. J., Verrier R. L., Lown B.. The repetitive extrasystole as an index of vulnerability to ventricular fibrillation. Am. J. Physiol. 1976; 230: 1469
38 Maseri A., L'Abbate A., Baroldi G.. et al. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from study of preinfarction angina. New Engl. J. Med. 1978; 229: 1271-1277
39 Maseri A.. et al. »Variant« angina: one aspect of a continous spectrum of vasospastic myocardial ischaemia. Am. J. Cardiol. 1978; 42: 1019
40 Maseri A., Chierchia S., L'Abbate A.. Pathogenetic mechanism underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62 (Suppl. V) 3-13
41 Lown B., Verrier R. L.. Neural activity and ventricular fibrillation. New Engl. J. Med. 1976; 294: 1165-1170
42 Lown B., Verrier R. C., Rabinowitz S. J.. Neural and psychologic mechanism and the problem of sudden cardiac death. Am. J. Cardiol. 1977; 39: 890-902
43 Engel G. L.. Sudden death and rapid death during psychologic stress. Folklore or folk wisdom. Ann. intern. Med. 1971; 74: 771-782
44 Taggart P., Carruthers M., Somerville W.. Electrocardiograms. plasma catecholamines and lipids and their modification by Oxprenolol when speaking before an audience. Lancet 1973; 2: 341-346
45 Cobb L. A., Werner J. A.. Antiarrhythmic therapy. Ventricular depolarization and sudden death. The tip of the iceberg (editorial). Circulation 1979; 59: 864-865
46 Valentine P. A.. Lidocain in the prevention of sudden death in the prehospital phase of acute myocardial infarction. New Engl. J. Med. 1974; 291: 1327-1331
47 Singh J. B., Kocot S. L.. A controlled trial of intramuscular lidocain in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am. Heart J. 1976; 91: 430
48 Lie K. J., Liem K. L., Louridzt W. J., Janse M. J., Willebrands A. F., Durrer D.. Efficacy of lidocain in preventing primary fibrillation within 1 hour after a 300 mg intramuscular injection. A double blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am. J. Cardiol. 1978; 42: 486
49 Bernstein V., Bernstein M., Griffith J.. et al. Lidocain intramusculary in acute myocardial infarction. JAMA 1972; 279: 1027-1031
50 Cohen L. S., Rosenthal J. E.. et al. Plasma levels of lignocaine after intramuscular administration. Am. J. Cardiol. 1972; 29: 520-523
51 Ryden L., Wasir H., Conradsson T. B.. et al. Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction. Brit. Heart J. 1972; 34: 1012-1017
52 Scott D. B., Vellani C. W., Jebson P. J.. et al. Plasma levels of lignocaine after intramuscular injection. Lancet 1968; 2: 1209-1210
53 Zener J. C., Kerber R. E., Spivak A. P., Harrison D. C.. Blood lidocain levels and kinetics following highdose intramuscular administration. Circulation 1973; 47: 984
54 Ribner H. S., Isaacs E. S., Frishman W. H.. Lidocain prophylaxis against ventricular fibrillation in acute myocardial infarction. Prog. Cardio-vasc. Dis. 1979; 21: 287
55 Lie K. J., Wellens H. J. J., van Capelle F. J., Durrer D.. Lidocaine in the prevention of primary ventricular fibrillation. A double blind randomized study of 212 consecutive patients. New Engl. J. Med. 1974; 291: 1324
56 Harrison D. C. Should lidocain be administered routinely to all patients after acute myocardial infarction? (editorial). Circulation 1978; 58: 581-584
57 Killip T.. Arrhythmias in myocardial infarction. Med. Clin. N. Amer. 1976; 60: 233
58 Scheinman M. M., Remedios P., Cheitlin M. D.. et al. Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction. Circulation 1980; 62: 20
59 Rudolph W., Dirschinger J.. Standardtherapie des akuten Myocardinfarktes. Herz 1981; 6: 1-13
60 Barber J. M., Mc D. C., Boyle HussainZ.. et al. Simple lignocaine regimen for transit to hospital after myocardial infarction. Brit. Heart J. 1977; 39: 1361
61 Ryden L., Waldenstrom A.. et al. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmias complicating acute myocardial infarction. Brit. Heart J. 1973; 35: 1124-1131
62 Campbell N. P. S., Kelly J. G., Adgey A. A. J., McDevitt D. G., Pantridge J. F.. Observations on intravenous administration of lignocaine in patients with myocardial infarction. 1978; Brit. Heart J. 40: 1371
63 Sheridan D. J., Crawford L., Rawlins M. D., Julian D. G.. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration. Lancet 1977; 1: 824
64 Bleifeld W., Merx W., Heimich K. W., Effert S.. Lidocain zur Arrhythmieprophylaxe beim frischen Herzinfarkt. Verh. dtsch. Ges. inn. Med. 1972; 78: 1035
65 Jennings G., Model D. C., Jones M. B. D.. et al. Oral disopyramid in prophylaxis of arrhythmias following myocardial infarction. Lancet 1976; 1: 51
66 Aschuff S. C., Campbell R. W.. et al. Mexiletine in the prevention of ventricular dysrhythmias in acute myocardial infarction. Circulation 1975; 51/52 (Suppl. II) 147
67 Merx W., Franken G., Effert S.. Mexitil beim akuten Herzinfarkt. Z. Kardiol. 1980; 69: 204
68 Kosowsky B. D., Taylor J., Lown B., Ritchie R. T.. Long-term use of procainamid following acute myocardial infarction. Circulation 1973; 47: 1204-1210
69 Collaborative Group Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2. 1971; 1055-1057
70 Vajda F. J. E., Prineas R. J., Lovell R. R. H., Sloman J. G.. The possible effect of longterm high plasma levels of phenytoin on mortality after acute myocardial infarction. Europ. J. Clin. Pharmacol. 1973; 5: 138
71 Lovell R. R. H.. Review of the present status of drug treatment for preventing sudden death. Brit. Heart J. 40 (Suppl.) 1978; 94-98
72 Peter Th., Ross D.. et al. Effect on survival after myocardial infarction of longterm treatment with phenytoin. Brit. Heart J. 1978; 40: 1356-1360
73 van Durme J. P., Bogaert M. G.. Prevention of sudden death: The role of antiarrhythmic therapy. In Kulbertus H. E., Wellens H. J. J.. (eds) Sudden death. Martinus Nijhoff-Publishers The Hague, Boston; London: 1980: 324-327
74 Hagemeijer F., Glaser B., van Durme J. P., Bogaert M.. Design of a study to evaluate drug therapy of serious ventricular rhythm disturbances after an acute myocardial infarction. Europ. J. Cardiol. 1977; 6: 299-310
75 Chamberlain D. A.. Oral mexiletine in high risk patients after acute myocardial infarction. VIII European Congress of Cardiology, Paris, 217 (abstr) 1980
76 Campbell N. P. S., Pantridge J. T., Adgey A. A. J.. Longterm oral antiarrhythmic therapy with mexitil. Brit. Heart. J. 1978; 40: 796-801
77 Lichtlen P. R., Bethge K. P., Godt U.. Zum Problem der antiarrhythmischen Langzeittherapie nach Infarkt. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber Bern, Stuttgart; Wien: 1980: 201-219
78 Breithardt G., Seipel L., Loogen F.. Der akute Herztod - Bedeutung elektrophysiologischer Stimulationsverfahren. Verh. dtsch. Ges. Herz- u. Kreislaufforschg. 1980; 46: 38-64
79 Engel T. R., Mendizabal R., Meister S. G., Bentivoglio L. G.. Testing for ventricular tachycardia with programmed extrasystoles in sinus rhythm. Circulation 1975; 52 (Suppl. II) 178
80 Horowitz L. N., Josephson M. E., Farshidi A.. et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimes. Circulation 1978; 58: 986
81 Mason J. W., Winkle R. A.. Electrode - catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 1978; 58: 971
82 Ruskin J. N., di Marco J. P., Garan H.. Out of hospital cardiac arrest. electrophysiologic observations and selecting of long term antiarrhythmic therapy. New Engl. J. Med. 1980; 303: 607-613
83 Warnowicz M. A., Denes P.. Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity. Progr. Cardiovasc. Dis. 1980; 23: 225-236
84 Zipes D. P.. New approaches to antiarrhythmic therapy. New Engl. J. Med. 1981; 304: 475-476
85 Wellens H. J. J., Bär F.. Clinical relevance of tachycardias induced during programmed cardiac stimulation. Am. J. Cardiol. 1979; 43: 400 (abstr.)
86 Fisher D. H.. Ventricular tachycardia - practical and provocative electrophysiology (editorial):. Circulation 1978; 58: 1000
87 Breithardt G., Seipel L., Haerten H., Abend-rot L., Loogen R.. Effektivitätskontrolle der antiarrhythmischen Therapie bei Patienten mit chronisch rezidivierenden, ventrikulären Tachykardien mittels elektrophysiologischer Stimulationsverfahren. Z. Kardiol. 1979; 68: 725
88 Collins jr. J. J.. Surgery for intractable ventricular arrhythmias. New Engl. J. Med. 1980; 302: 627-628
89 Fontaine G., Frank R., Guiraudon G.. et al. Surgical treatment of resistant reentrant ventricular tachycardia by ventriculotomy. A new application of epicardial mapping. Circulation 1974; 49/50 (Suppl. III) 82
90 Guiraudon G., Fontaine G., Frank R.. Circular endocardial ventriculotomie.A new surgical treatment for life threatening ventricular tachycardia resistant to medical treatment following myocardial infarction. Ann. Thoracic. Surg. 1978; 26: 438
91 Kaiser G. A., Waldo A. L., Beach P. M.. et al. Specialized cardiac conduction-system. Improved electrophysiologic identification technique at surgery. Arch. Surg. 1970; 101: 673
92 Lown B., Th B.Graboys. Management of patients with malignant ventricular arrhythmias. Am. J. Cardiol. 1977; 39: 910-918
93 Hjalmarson A.. Prevention of sudden death. The role of Betablockers. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers. The Hague; Bosten, London: 1980: 313-323
94 A Multicenter International Study Improvement in prognosis of myocardial infarction by longterm betaadrenoreceptor blockade using practolol. Brit. med. J. 1977; 735-740 III
95 Multicentre International Study Supplementary report: Reduction in mortality after myocardial infarction with longterm betaadrenoreceptor-blockade (K. G. Green). Brit. med. J. 1977; II 419-421
96 Schröder R.. Prävention des Reinfarktes und des plötzlichen Herztodes. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber, Bern; Stuttgart, Wien: 1980: 165-177
97 Barber J. M., Boyle M. C.. et al. Practolol in acute myocardial infarction. Acta med. Scand. Suppl. 1976; 587: 213-216
98 Ahlmark G., Saetre H.. Longterm treatment with betablockers after myocardial infarction. Europ. J. Clin. Pharmacol. 1976; 10: 77
99 Ahlmark G., Saetre H., Korsgren M.. Reduction of sudden death after myocardial infarction. Lancet 1974; 2: 1563
100 Andersen M. P., Bechsgaard P., Frederikse J.. et al. Effect of alprenolol on mortality among patients with definitive or suspected myocardial infarction. Preliminary results. Lancet 1979; 2: 865-868
101 Reynolds J. L., Whitelock R. M. L.. Effects of a beta adrenergic receptorblocker in myocardial infarction treated for one year from onset. Brit. Heart J. 1972; 34: 252
102 Wilhelmsson C, Vedin J. A., Wilhemsen L., Tibblin G., Werkö L.. Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet 1974; 2: 1157
103 Vedin A., Wilhelmsson C., Tibblin G., Werkö L.. Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta. med. Scand. Suppl. 1975; 575: 7
104 Baber N. S.. et al. Multicentre postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Brit. Heart J. 1980; 44: 96-100
105 Sloman G., Stannard M.. Beta adrenergic blockade and cardiac arrhythmia. Brit. med. J. 1967; 508. IV
106 Winkle R. A., Gradman A. H., Fitzgerald J. W.. Antiarrhythmic drug effect assessed from ventri-cular anhythmia reduction in the ambulatory electrocardiogram and tread mill test: Comparison of propranolol, procainamid and quinidine. Am. J. Cardiol. 1978; 42: 473
107 Sinn R., Wolf R., Pretschner P., Hundesha-gen H., Koeffler H., Dopslaff H.. Häufigkeit und Bedeutung ventrikulärer Arrhythmien unter medikamentöser Prophylaxe nach Myocardinfarkt. Z. Kardiol. 1980; 69: 225
108 Godt U., Bethge K. P., Lichtlen P. R.. Rhythmusstörungen und plötzlicher Herztod im frühen Postinfarktstadium. Z. Kardiol. 1980; 69: 226
109 Wellens H. J. J., Bär F., Lie K. J.. et al. Effect of procainamid, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am. J. Cardiol. 1977; 40: 579
110 Ritchie J. L., Harker L. A.. The possible role of platelets in sudden cardiac death. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers; The Hague, Boston, London: 1980: 328-334
111 Overschl K. W., So Baedecker C. S.. Wirkung von Betarezeptorenblockern auf die Thrombozytenaggregation bei coronarer Herzkrankheit. Z. Kardiol. Suppl. 1978; 5: 78
112 Sherry S.. The Anturan Reinfarction Trial. Circulation 1980; 62: 73-78 (Suppl/V)
113 Gülker R. F., Bender J.Thaler, Heuer R., Dorsel T., Pierchalter P.. Fehlende antiarrhythmische und antifibrillatorische Wirkung von Sul-finpyrazolon beim akuten Myocardinfarkt. Z. Kardiol. 1980; 69: 206
114 Moschos C., Escobias A., Jorgensen O., Regan T.. Effect of sulfinpyrazon on survival following experimental non thrombotic coronary occlusion. Am. J. Cardiol. 1979; 43: 372
115 Wilcox R. G., Richardson D., Hampton J. R., Mitchell J. R. A., Banks D. C.. Sulfinpyrazon in acute myocardial infarction: Studies on cardiac rhythm and renal function. Brit. med. J. 1980; 281: 531